Members of the Polycomb-group (PcG) family of proteins, including EZH2 (enhancer of zeste homolog 2), are involved in establishing epigenetic silencing of developmental genes in adult and embryonic stem cells, and their deregulation has been implicated in cancer. In a recent report, EZH2-mediated epigenetic repression of DNA damage repair in breast tumor initiating cells (BTICs) was identified as a mechanism that could promote expansion of BTICs, and may contribute to cancer progression.
Hiroaki Taniguchi, Filipe V. Jacinto, Alberto Villanueva, Agustín F. Fernández, Hiroyuki Yamamoto, F. Javier Carmona, Sara Puertas, Víctor E. Márquez, Yasuhisa Shinomura, Kohsuke Imai, Manel Esteller
Maria Carmela Vegliante, Cristina Royo, Jara Palomero, Itziar Salaverría, Balázs Bálint, Idoia Martín‐Guerrero, Xabier Agirre, Amaia Lujambio, Julia Richter, Sílvia Xargay‐Torrent, Sı́lvia Beà, Luís Hernández, Anna Enjuanes, Marı́a José Calasanz, Andreas Rosenwald, German Ott, José Román‐Gómez, Felipe Prósper, Manel Esteller, Pedro Jares, Reiner Siebert, Elı́as Campo, José I. Martı́n-Subero, Virginia Amador
Vincenzo Calvanese, Angélica Horrillo, Abdelkrim Hmadcha, Beatriz Suárez-Álvarez, Agustín F. Fernández, Ester Lara, Sara Casado, Pablo Menéndez, Clara Bueno, Javier García‐Castro, Ruth Rubio, Pablo Lapunzina, Miguel Alaminos, Lodovica Borghese, Stefanie Terstegge, Neil J. Harrison, H. D. M. Moore, Oliver Brüstle, Carlos López‐Larrea, Peter W. Andrews, Bernat Soria, Manel Esteller, Mario F. Fraga
Discussion(0)
No comments yet. Be the first to comment.